ORAI1 and rheumatic disorder: ORAI1 is also commonly reported as a target for diseases implicating inflammatory processes, including arthritis, asthma, cancer, conjunctivitis, COVID-19, pancreatitis, pneumonia, psoriasis, or rheumatism (65–67).